Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Clq deficiency is linked to systemic lupus erythematosus symptoms.

Most patients improved with oral contraceptives, but some needed additional treatment.

Stilbamidine and hydroxystilbamidine inhibit enzyme release from lysosomes and have effects similar to cortisol and chloroquine.

Alopecia areata is linked to autoimmune antibodies.

The combination therapy may be more effective for mild alopecia areata, especially in patients with allergies.

Azithromycin can rarely cause a severe drop in white blood cells.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

Valproic acid is effective for controlling seizures in children, especially as a single treatment, with some side effects.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

Zinc sulphate solution was not effective in reducing the number, duration, or severity of recurrent herpes simplex infections.

The document describes a way to measure biotin in blood to prevent wrong test results in hormone level testing.

Baricitinib is effective and safe for treating severe alopecia areata.

IL-3 worsens lupus nephritis and blocking it improves kidney health.

Complete COVID-19 vaccination reduces the risk of long COVID.

CCL 27 levels are similar in people with and without alopecia areata.

Adalimumab can cause complete hair loss in rare cases.

Upadacitinib improved multiple immune-related conditions in one patient.

Mononuclear cells may protect against certain chemotherapy-induced hair loss.

Finasteride effectively reduces DHT and E2 levels, helping with prostate enlargement.

Alopecia areata is linked to reduced T cell function and auto-immunity.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Enhancing immune response can improve cancer treatment effectiveness.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

Oxidative stress contributes to hair graying and loss as we age.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

The conclusion suggests that treatments targeting root causes of chronic diseases may be developed by focusing on gene expression and lifestyle factors.

Sequential immunotherapy can effectively treat alopecia areata by managing inflammation and promoting hair regrowth.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.